Exchange Surveillance
No active ASM or GSM measures on this stock.
Price band ± 20%
Price
Trading Data
range barsReturns
absolute and vs benchmark indexAbout the Company
Dr Agarwals Eye Hospital Ltd has always been at the forefront of every medical advancement in the field of Ophthalmic care in the world and has several firsts to its credit. The Hospital is engaged in conducting continuous training and research and development programs and has over a period, developed an excellent team of highly skilled Ophthalmic specialists and surgeons, to assist in their growth plans.Services offered by the company include:Intralase Surgery,Zyoptix / Lasik Laser,Customise your Eyes,Cataract Surgery and Phaco / Zyoptix Professional..The company also in the business segment of Medical Services, Trading Activities.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- HQ
- Chennai (Madras), Tamil Nadu
- Chairman
- Amar Agarwal
- CEO & MD
- Amar Agarwal
- Registrar
- Integrated Registry Management Services Pvt. Ltd.
- Exchange
- NSE
- ISIN
- INE934C01018
Institutional Demand
passive ownership through ETFsContext
where this company sitsFrequently Asked
▶What is the share price of Dr Agarwals Eye Hospital Ltd-$ today?
Dr Agarwals Eye Hospital Ltd-$ (DRAGARWQ) is trading at ₹5,077. The price shown is the latest available from the exchange feed and updates through the trading session.
▶What is DRAGARWQ’s P/E ratio versus the sector?
DRAGARWQ trades at a P/E of 32.9. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.
▶What is DRAGARWQ’s dividend yield?
DRAGARWQ has a dividend yield of 0.13%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.
▶What is DRAGARWQ’s 52-week high and low?
DRAGARWQ has traded between ₹5,035.5 and ₹5,500 over the past year. The Trading Data block shows where the current price sits inside that band.
▶What is the market capitalisation of Dr Agarwals Eye Hospital Ltd-$?
Dr Agarwals Eye Hospital Ltd-$ has a market capitalisation of ₹2,511 crore.
▶What is DRAGARWQ’s return on equity?
DRAGARWQ reports a return on equity of 24.2%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Medical Care Facilities.
▶Who are DRAGARWQ’s competitors?
The Peers block on this page lists other Medical Care Facilities companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.
▶What is DRAGARWQ’s promoter holding?
Promoters hold 72.67% of DRAGARWQ. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.
▶Which indices include DRAGARWQ?
Index membership is listed in the Context block on this page, along with the weight DRAGARWQ carries in each. That weight is what determines how much passive money tracks the stock.
▶Is Dr Agarwals Eye Hospital Ltd-$ a good buy?
We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from DRAGARWQ’s own numbers. The judgement is yours.
DRAGARWQ at a glance
Dr Agarwals Eye Hospital Ltd operates in the Medical Care Facilities industry, part of the Healthcare sector. Dr Agarwals Eye Hospital Ltd (DRAGARWQ) last traded at ₹5,077, giving it a market capitalisation of ₹2,511 crore. The 52-week range is ₹5,035.5 to ₹5,500, and the price is 9% of the way up that range. It trades at a price-to-earnings ratio of 32.9. Promoters hold 72.67% of the company in the latest shareholding filing.
| Market cap | ₹2,511 crore |
|---|---|
| P/E | 32.9 |
| ROE | 24.2% |
| ROCE | 17.2% |